Skip to main content

Time in Range News

Time in Range (TIR) is the percentage of time that a person spends with their blood glucose levels in the target range, usually between 70 and 180 mg/dl.

FDA approves WellDoc’s BlueStar app (24/7 diabetes management coaching and support) for use in type 1 diabetes. BlueStar insights also now incorporate data from Dexcom...
En el Mes Nacional de la Salud de las Minorías, el autor comparte la historia de su diagnóstico de diabetes tipo 2
Rybelsus, a GLP-1 agonist pill already approved in Europe and the US, has just been approved by Health Canada for adults with type 2 diabetes
Health Canada authorizes the latest temporary approval for CGM during the pandemic: the Dexcom G6 is now available to pregnant women with diabetes
Expert physicians share a few of the benefits of virtual appointments for people living with diabetes
Enroll in Level2 to get a CGM, a Fitbit activity tracker, and easily accessible virtual health coaching; the program is designed to help people achieve type 2 diabetes...
In-person visits, lab tests, and finger stick documentation are no longer required at present to get a CGM
Major milestones in 2019 brought time in range to the forefront of diabetes care
The diaTribe team was on the ground in Madrid, Spain to cover the latest news in diabetes technology from ATTD. Here are our top highlights from the conference!
The ADA Scientific Sessions starts later this week – we've highlighted some of the most important presentations and posters for you to look forward to
In exciting news, Tandem announced expanded clearance for the hybrid closed loop Control-IQ. The system is now available for children ages 6-13
The Time in Range Coalition aims to help millions of people by promoting time in range in diabetes care
The G6 Pro includes several exciting new features and is expected to start shipping next week!
Mark Harmel, MPH, CDCES, discusses how his clinic is moving to telemedicine in the time of COVID-19 and how to share data from many diabetes devices
dQ&A surveyed 2,540 CGM users with type 1 or type 2 diabetes to find out how aware they are of their own time in range: 87% of respondents knew how much time they...
Dr. Anne Peters shares insights on how healthcare professionals can help people ease the challenges of managing diabetes during COVID and how the shift to telemedicine...
We interviewed Dr. Partha Kar to learn about how people are using time in range in his clinic and what obstacles our society will need to overcome to promote wider use...
Highlights from last week’s European Association for the Study of Diabetes’ (EASD) virtual 2020 conference included announcements on the Guardian Sensor 4 Continuous...
Fitbit’s new glucose tracking feature allows users to log blood glucose meter data alongside activity, sleep, food, and more in the Fitbit app. Learn how your daily...
Professor Simon Heller is known globally for his renowned research on hypoglycemia; hear his opinion on using Time in Range in diabetes management

Pages